rs876657709
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_004999.4(MYO6):c.2814_2815delAA(p.Arg939ThrfsTer2) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000658 in 152,080 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_004999.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152080Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 250946Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135790
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152080Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74280
ClinVar
Submissions by phenotype
not provided Pathogenic:2
This sequence change creates a premature translational stop signal (p.Arg939Thrfs*2) in the MYO6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MYO6 are known to be pathogenic (PMID: 12687499, 18348273, 23767834, 25999546, 30582396). This variant is present in population databases (rs753233152, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with deafness (PMID: 25227905). ClinVar contains an entry for this variant (Variation ID: 228375). For these reasons, this variant has been classified as Pathogenic. -
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at a significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25227905) -
Rare genetic deafness Pathogenic:1
The p.Arg939fs variant in MYO6 has been previously reported in 1 individual with nonsyndromic hearing loss and was found to segregate with disease in 14 affecte d family members in an autosomal dominant manner (Cheng 2014). It has also been identified in 1/66162 European chromosomes by the Exome Aggregation Consortium ( ExAC, http://exac.broadinstitute.org). This variant is predicted to cause a fram eshift, which alters the protein?s amino acid sequence beginning at position 939 and lead to a premature termination codon 2 amino acids downstream. This altera tion is then predicted to lead to a truncated or absent protein. Truncating or l oss-of-function variants in the MYO6 gene have been associated with autosomal re cessive congenital sensorineural hearing loss (Ahmed 2003) as well as autosomal dominant postlingual/late-onset progressive sensorineural hearing loss with vari able onset and severity (Hilgert 2008, Sanggaard 2008, Neveling 2013, Schrauwen 2013, Volk 2013). In summary, this variant meets our criteria to be classified a s pathogenic for dominantly inherited nonsyndromic hearing loss based upon the s egregation studies in the reported family and its predicted impact to the protei n. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at